SIRT1 and Disorder of lipid metabolism: Compared with quercetin treatment, pioglitazone treatment did not significantly affect the SIRT1/Akt pathway, and this finding reveals the advantage of quercetin in the treatment of glucose and lipid metabolism disorder to some degree.